TouchMDT – Impact Of Pharmacotherapies For Achondroplasia

touchpodcast에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 touchpodcast 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

touchPODCAST « »
touchMDT – Impact of pharmacotherapies for achondroplasia – Discussion 4

15d ago 19:20

MP3•에피소드 홈

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia

The multidisciplinary team and patient advocate:

MFM specialist - Prof. Karin Blakemore
Johns Hopkins University School of Medicine, Baltimore, MD, USA

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike
Otto-von-Guericke University Magdeburg, Magdeburg, Germany

Paediatrician - Prof. Janet Legare
University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Patient advocate - Ms Carly Kutner
Freehold, NJ, USA

This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

102 에피소드

#Science #TouchPODCAST